ENVB vs. FMED
ENVB (Enveric Biosciences Inc) is a stock, while FMED (Fidelity Disruptive Medicine ETF) is Health & Biotech Equities fund actively managed by Fidelity. Over the past 3 years, ENVB returned -87.52%/yr vs 0.73%/yr for FMED. At a 0.24 correlation, their price movements are largely independent.
Performance
ENVB vs. FMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -59.23% return, which is significantly lower than FMED's -4.75% return.
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
FMED
- 1D
- 0.90%
- 1M
- 7.10%
- YTD
- -4.75%
- 6M
- -6.17%
- 1Y
- 8.53%
- 3Y*
- 0.73%
- 5Y*
- —
- 10Y*
- —
ENVB vs. FMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -65.79% |
FMED Fidelity Disruptive Medicine ETF | -4.75% | 9.69% | 2.29% | -3.59% |
Correlation
The correlation between ENVB and FMED is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. FMED — Risk / Return Rank
ENVB
FMED
ENVB vs. FMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVB | FMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.96 | ||
| Sortino ratioReturn per unit of downside risk | -1.80 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.09 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.98 | 0.47 | -1.45 |
| Martin ratioReturn relative to average drawdown | -1.34 | 1.03 | -2.38 |
Loading charts...
Drawdowns
ENVB vs. FMED - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for ENVB and FMED.
Loading charts...
Drawdown Indicators
| ENVB | FMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -21.84% | -78.16% |
Max Drawdown (1Y)Largest decline over 1 year | -91.49% | -18.33% | -73.16% |
Max Drawdown (3Y)Largest decline over 3 years | -99.81% | -21.84% | -77.97% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -10.64% | -89.36% |
Average DrawdownAverage peak-to-trough decline | -86.07% | -7.09% | -78.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.73% | 8.27% | +58.46% |
Volatility
ENVB vs. FMED - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 21.07% compared to Fidelity Disruptive Medicine ETF (FMED) at 7.50%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | FMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.07% | 7.50% | +13.57% |
Volatility (6M)Calculated over the trailing 6-month period | 105.59% | 15.01% | +90.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 175.01% | 19.37% | +155.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 155.96% | 18.57% | +137.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 164.65% | 18.57% | +146.08% |
Dividends
ENVB vs. FMED - Dividend Comparison
Neither ENVB nor FMED has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% |
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
Frequently Asked Questions
ENVB and FMED have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to FMED (7.50%). In terms of maximum drawdown, ENVB dropped -100.00% vs FMED's -21.84%.
FMED currently has the higher Sharpe Ratio (0.44 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and FMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer